Form D · Biotechnology
ANTERIOS INC
New York, NY · CIK 0001390085
Offering snapshot reported Apr 9, 2013 · SEC filing
- Reported sold
- $4.74M Offering amount: $6.61M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 25, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 9, 2013 | Initial | $4,744,055 | No comparison | 12 | SEC filing |
| Jul 22, 2011 | Initial | $3,035,007 | No comparison | 10 | SEC filing |
| Dec 29, 2010 | Initial | $1,999,992 | No comparison | 1 | SEC filing |
| Sep 3, 2010 | Initial | $750,000 | No comparison | 6 | SEC filing |
| Feb 18, 2010 | Initial | $1,500,000 | No comparison | 1 | SEC filing |
| Oct 21, 2009 | Initial | $5,165,495 | No comparison | 15 | SEC filing |
| Jan 30, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-194710
Source: Form D, filed Apr 9, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jon Edelson | Director, Executive |
| Carter Meyer | Director |
| Geoffrey Smith | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
142 West 57th Street, Suite 4 A
New York, NY, 10019
New York, NY, 10019